About: http://data.cimple.eu/news-article/3e0198bfacec69d329fb6a83590d2b212b4807dd0a51dd1699de6655

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/3e0198bfacec69d329fb6a83590d2b212b4807dd0a51dd1699de6655 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their Covid-19 vaccine candidate to the Canadian government, which has already signed similar agreements with several American companies. The two groups, which plan to seek regulatory approval for the vaccine in the first half of 2021, launched human clinical trials in early September, for which 440 participants are being recruited. "To address a global health crisis of this magnitude, it takes partnerships and we are grateful to Canada for their collaboration, and to GSK for partnering with us to develop a safe and effective vaccine," Sanofi Pasteur vice president Thomas Triomphe said in a joint statement. The vaccine candidate, developed by Sanofi in partnership with GSK, is based on technology that Sanofi has used to produce seasonal influenza vaccines and on immunological agents developed by GSK. Canada already signed in August agreements in principle for candidate vaccines with American firms Novavax, Johnson & Johnson, Pfizer and Moderna Ottawa has requested from Moderna an additional 14 million additional doses, Procurement Minister Anita Anand said on Monday. In total, "Canada has now ensured guaranteed access to a minimum of 154 million doses and up to a maximum of 262 million potential vaccines to protect Canadians and save lives," she told a news conference. Ottawa also announced an agreement with Gilead Sciences and McKesson Canada for up to 150,000 vials of remdesivir, an antiviral used in the treatment of seriously ill Covid-19 patients. Canada approved its use at the end of July. As of Monday, Canada, which has a population of nearly 38 million, had recorded more than 146,000 cases of the new coronavirus and 9,269 deaths. Several countries have already reserved doses of the vaccine candidate from Sanofi and GSK -- 60 million doses have been promised to the British government, the European Commission has reserved 300 million, and the United States 100 million with an option for up to 500 million additional doses over the longer term. mlb-et/amc/adp
schema:headline	Sanofi and GSK to provide 72 million vaccine doses to Canada
schema:mentions	Global health Novavax European Commission Antiviral drug Remdesivir Johnson & Johnson Medication Clarence Thomas French language Moment magnitude scale Influenza vaccine Ottawa Canada Pfizer United Kingdom Vaccine United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Gdańsk Agreement Anita Anand McKesson Corporation Sanofi Pasteur AMC Networks Gilead Sciences Sanofi Adenosine diphosphate
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-09-22 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	92 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software